M

MeiraGTx Holdings plc
D

MGTX

5.11000
USD
0.07
(1.39%)
مغلق
حجم التداول
16,936
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
410,666,984
أصول ذات صلة
LI
LI
0.255
(0.89%)
28.905 USD
N
NIO
-0.06500
(-1.68%)
3.81500 USD
RIVN
RIVN
-0.420
(-2.62%)
15.620 USD
TSLA
TSLA
-5.98
(-1.73%)
339.30 USD
W
WKHS
0.02400
(2.84%)
0.87000 USD
XPEV
XPEV
-0.180
(-0.89%)
19.980 USD
المزيد
الأخبار المقالات

العنوان: MeiraGTx Holdings plc

القطاع: Healthcare
الصناعة: Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.